Related Articles
Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method
Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver
Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis
Role of the long non‑coding RNA‑Annexin A2 pseudogene 3/Annexin A2 signaling pathway in biliary atresia‑associated hepatic injury